- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:58 | HHS details plan to regain the US's edge in clinical trials | ||
| 12:58 | Pfizer's Seagen-derived ADC pipeline suffers a setback | ||
| 11:58 | MSD's TL1A drug tulisokibart delivers in pivotal IBD trial | ||
| 10:58 | Sanofi's type 1 diabetes-delaying drug cleared for NHS use | ||
| Mo | CARSgen bags world-first approval for solid tumour CAR-T | ||
| Mo | AbbVie climbs post-Allergan M&A peak with Apogee buy | ||
| Mo | Boehringer advances duo for aggressive cancers into phase 3 | ||
| Mo | Genpact finds $18tn in trapped AI value | ||
| Mo | Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance | ||
| Mo | Sanofi names ex-Roche exec Fontoura as R&D chief | ||
| Fr | US launches probe of German 'underpayment' for medicines | ||
| Fr | Which biotechs have raised new VC financing this week? | ||
| Fr | FDA experts endorse Moderna's mRNA seasonal flu shot | ||
| Do | MSD takes on Pfizer's Prevnar with new Capvaxive approval | ||
| Do | FDA approves first generic of Roche's flu drug Xofluza | ||
| Do | Heart drug biotech Kardigan raises $400m in upscaled IPO | ||
| Do | UK will be first market for Sanofi's subcutaneous Sarclisa | ||
| Do | GSK claims FDA okay for first oral carbapenem antibiotic | ||
| Do | AI agents can beat doctors in clinical decision-making | ||
| Do | Biogen pens $1bn deal to buy immunology biotech RayThera | ||
| Mi | uniQure sets course to US filing for Huntington gene therapy | ||
| Mi | Jazz orchestrates a $4bn cancer alliance with AbCellera | ||
| Mi | MSD steps out with Protillion in $510m+ AI shindig | ||
| Mi | Moderna builds commercial muscle as new launches loom | ||
| Mi | Hacking ring seeks to extort Novo Nordisk after cyberattack |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.